EMILY MANLEY: Open Payments
NPI 1144544834 · LAURENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 101 payments from 18 companies in 2025. Trend: 2023 $1,215 · 2024 $2,195 · 2025 $1,995
Food & beverage: $1,995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $525 |
| UCB, Inc. | 12 | $225 |
| Novartis Pharmaceuticals Corporation | 8 | $196 |
| Organon LLC | 9 | $182 |
| GENZYME CORPORATION | 5 | $167 |
| LEO Pharma Inc. | 5 | $119 |
| Janssen Biotech, Inc. | 5 | $98 |
| Lilly USA, LLC | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Galderma Laboratories, L.P. | 4 | $71 |
Products named: RINVOQ, DUPIXENT, Bimzelx, SKYRIZI, ADBRY, VTAMA, TREMFYA, COSENTYX.
Industry payments across GA — which companies pay providers there.
